All manufacturing activities at Indian Pharma company Marion Biotech Pvt Ltd have been stopped following allegations by Uzbekistan that at least 18 children died in the country after consuming the medicine.
The manufacturing activities have been stopped after the inspection by the Central Drugs Standard Control Organisation (CDSCO). A joint inspection of the manufacturer’s Noida facility was carried out by the teams of the Uttar Pradesh Drug Control Department and CDSCO.
“Following inspection by @CDSCO_INDIA_INF team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing”, said Union Health Minister Mansukh Mandaviya in a tweet on Friday.
However, the further investigation is in progress by the government agencies. The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing.
The All India Institute of Medical Sciences (AIIMS) has signed a Memorandum of Understanding (MoU)…
As many as one-third of all urban children in India aged 5-15 years are expected…
The Supreme court has reserved its order on a contempt plea against Baba Ramdev, Acharya…
Although nutrition and health claims are regulated by FSSAI, consumers are advised to exercise caution…
The Indian Council of Medical Research (ICMR) has warned that food labels on packaged items…
Approximately 10,000 children are born with Thalassemia each year, a genetic disorder impairing the body's…